• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

    4.705 -0.205 (-4.18%)
    Streaming Delayed Price Updated: 3:57 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,796
    Open 4.910
    Bid (Size) 4.500 (100)
    Ask (Size) 5.400 (800)
    Prev. Close 4.910
    Today's Range 4.596 - 4.930
    52wk Range 2.980 - 63.90
    Shares Outstanding 145,148,593
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
    This strategic engagement is designed to strengthen NeuroThera’s U.S. market position, visibility among key U.S. federal stakeholders, reinforce the clinical and public‑health importance of advancing... 
    Via TheNewswire.com

    Performance

    YTD
    -62.7%
    -62.7%
    1 Month
    -29.0%
    -29.0%
    3 Month
    -16.1%
    -16.1%
    6 Month
    +30.8%
    +30.8%
    1 Year
    -88.3%
    -88.3%

    More News

    Read More
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
    From SciSparc Ltd
    Via GlobeNewswire
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial
    Via TheNewswire.com
    News headline image
    Neurothera Labs Inc. Announces Share Consolidation
    Via TheNewswire.com
    News headline image
    NeuroThera Labs Engages Dr. Reuter Investor Relations
    Via TheNewswire.com
    News headline image
    SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
    From SciSparc Ltd
    Via GlobeNewswire
    Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗
    Via Chartmill
    Top movers analysis one hour before the close of the markets on 2026-07-29: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    These stocks are moving in today's session ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Wednesday's session. ↗
    Via Chartmill
    News headline image
    SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
    From SciSparc Ltd
    Via GlobeNewswire
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    Which stocks are gapping on Thursday? ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Thursday. ↗
    Via Chartmill

    Frequently Asked Questions

    Is SciSparc Ltd. - Ordinary Shares publicly traded?
    Yes, SciSparc Ltd. - Ordinary Shares is publicly traded.
    What exchange does SciSparc Ltd. - Ordinary Shares trade on?
    SciSparc Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for SciSparc Ltd. - Ordinary Shares?
    The ticker symbol for SciSparc Ltd. - Ordinary Shares is SPRC on the Nasdaq Stock Market
    What is the current price of SciSparc Ltd. - Ordinary Shares?
    The current price of SciSparc Ltd. - Ordinary Shares is 4.705
    When was SciSparc Ltd. - Ordinary Shares last traded?
    The last trade of SciSparc Ltd. - Ordinary Shares was at 09/29/26 03:57 PM ET
    What is the market capitalization of SciSparc Ltd. - Ordinary Shares?
    The market capitalization of SciSparc Ltd. - Ordinary Shares is 682.92M
    How many shares of SciSparc Ltd. - Ordinary Shares are outstanding?
    SciSparc Ltd. - Ordinary Shares has 683M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.